Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28634176 | 0.80 | ALDH1A1 (0.41) | ALDH1A1RAB9APOLBLMNA | |
| SCHEMBL3292755 | 0.77 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL1196057 | 0.77 | ALDH1A1 (0.49) | ALDH1A1NPC1TSHRRAB9ASMN1; SMN2 | |
| SCHEMBL1409756 | 0.75 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL13517735 | 0.72 | ALDH1A1 (0.59) | ALDH1A1NPC1TSHRRAB9ASMN1; SMN2 | |
| SCHEMBL3150000 | 0.69 | POLB (0.51) | ALDH1A1SMN1; SMN2POLBLMNA | |
| SCHEMBL5838089 | 0.69 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL7723978 | 0.69 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2POLBHTTLMNA | |
| SCHEMBL5837416 | 0.69 | POLB (0.51) | ALDH1A1SMN1; SMN2POLBLMNA | |
| SCHEMBL5838085 | 0.69 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2POLBHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| CN-113316744-B | Oxime ester photoinitiators with special aroyl chromophores | 巴斯夫欧洲公司 | 2024-07-30 | — | — | CN | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-3044208-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-12-22 | — | — | EP | disclosed |
| US-10793555-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2020-10-06 | — | — | US | disclosed |
| US-20180208583-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-07-26 | — | — | US | disclosed |
| US-9957258-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2018-05-01 | — | — | US | disclosed |
| US-20160214966-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2016-07-28 | — | — | US | disclosed |
| US-20090169736-A1 | THERMOSETTING RESIN COMPOSITION, METHOD OF FORMING ANTIHALATION FILM OF SOLID-STATE IMAGING DEVICE, ANTIHALATION FILM FOR SOLID-STATE IMAGING DEVICES, AND SOLID-STATE IMAGING DEVICE | JSR CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793555-B2 | Oxime ester photoinitiators | NR2E3, OXER1, CBR3 | ALDH1A1 929/4885NPC1 3823/4885TSHR 310/4885 |
| US-20180208583-A1 | OXIME ESTER PHOTOINITIATORS | NR2E3, OXER1, CBR3 | ALDH1A1 929/4885NPC1 3823/4885TSHR 310/4885 |
| US-20160214966-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | ALDH1A1 854/4885NPC1 4754/4885TSHR 2377/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | ALDH1A1 964/4885NPC1 4686/4885TSHR 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.